Table 1 Baseline patient and treatment characteristics
Characteristic | Patients (n = 30) |
|---|---|
Sex | |
Female | 12 |
Male | 18 |
Ethnicity | |
Caucasian | 26 |
Other | 4 |
Tumor histology | |
Nonsquamous | 14 |
Squamous | 16 |
T Stage | |
T1 | 3 |
T2 | 12 |
T3 | 5 |
T4 | 10 |
TX | |
N Stage | |
N0 | 2 |
N1 | 3 |
N2 | 17 |
N3 | 8 |
Disease stage | |
IIB | 2 |
IIIA | 11 |
IIIB | 17 |
Response to ICT | |
Partial | 3 |
Progressive | 2 |
Stable | 27 |
ICT end to RT start (days) | |
Median | 18 |
Range | 1-80 |
RT dose (Gy) | |
Median | 70 |
Range | 60-74 |